Table 1 Creatine kinase and calcium plasma levels and renal function parameters of control and experimental groups, 4 days after saline or glycerol injections.

From: Protective effect of calcitriol on rhabdomyolysis-induced acute kidney injury in rats

 

Control

Control + Calcitriol

Glycerol

Glycerol + Calcitriol

CK

26.79 ± 1.59

24.57 ± 4.89

44.23 ± 7.51*,+

45.42±3.13*,+

Ca2+

10.04 ± 0.50

9.507 ± 0.41

8.144 ± 0.50

8.373 ± 0.19

Cr

0.610 ± 0.03

0.620 ± 0.05

2.73 ± 0.39*,+

2.07±0.43*,+

GFR

0.421 ± 0.06

0.490 ± 0.03

0.113 ± 0.02*,+

0.240 ± 0.04*,+,#

FENa+ (%)

0.290 ± 0.06

0.317 ± 0.05

3.713±0.51*,+

1.96±0.64+,#

Uosm

2080±241.6

1809±117.9

541.5±25.49*,+

696.0±33.45*,+

V

0.004 (0.002;0.01)

0.005 (0.003;0.01)

0.020 (0.01;0.02)*,+

0.013 (0.007;0.01)*,+,#

  1. CK, plasma creatine kinase (U/L); Ca2+, plasma calcium (mg/dL); Cr, plasma creatinine (mg%); GFR, glomerular filtration rate (ml min−1100 g−1); FENa+, fractional sodium excretion (%); Uosm, urinary osmolality (mOsm kg H2O−1); V, urinary flow (mL/min). The data are expressed as the mean ± SEM (GFR, FENa+ and Uosm) or median and interquartile range (25–75%). n = 7–12 per group. *P < 0.05 compared to Control; +P < 0.05 compared to Control +Calcitriol; #P < 0.05 compared to Glycerol.